Cargando…
CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings
BACKGROUND: Current guidelines regarding Lyme neuroborreliosis [LNB] require the presence of intrathecal Borrelia burgdorferi-specific antibody production for the definite diagnosis of LNB. However, about 20% of early stage infections present without an elevated antibody index. Moreover, intrathecal...
Autores principales: | Borde, Johannes P, Meier, Simone, Fingerle, Volker, Klier, Christiane, Hübner, Johannes, Kern, Winfried V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528660/ https://www.ncbi.nlm.nih.gov/pubmed/23228054 http://dx.doi.org/10.1186/1471-2334-12-344 |
Ejemplares similares
-
The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis
por: Henningsson, Anna J., et al.
Publicado: (2018) -
CXCL13 in laboratory diagnosis of Lyme neuroborreliosis—the performance of the recomBead and ReaScan CXCL13 assays in human cerebrospinal fluid samples
por: Haglund, Sofie, et al.
Publicado: (2021) -
Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection
por: Bremell, Daniel, et al.
Publicado: (2013) -
The special role of CXCL13 in Lyme neuroborreliosis: a case report
por: Erhart, Deborah K., et al.
Publicado: (2022) -
Borrelia miyamotoi–Associated Neuroborreliosis in Immunocompromised Person
por: Boden, Katharina, et al.
Publicado: (2016)